The Functional Gastrointestinal Disorders and the Rome III Process

Drossman, 1993, Psychosocial and psychophysiologic mechanisms in GI Illness, 41

Kroenke, 1989, Common symptoms in ambulatory care, Am J Med, 86, 262, 10.1016/0002-9343(89)90293-3

Drossman, 2005, Functional GI disorders, Gastroenterology, 128, 1771, 10.1053/j.gastro.2005.04.020

Drossman, 2001, Challenges in the physician-patient relationship, Gastroenterology, 121, 1037, 10.1053/gast.2001.28976

Mitchell, 1987, Survey of the AGA membership relating to patients with functional gastrointestinal disorders, Gastroenterology, 92, 1282, 10.1016/S0016-5085(87)91099-7

Russo, 1999, A national survey of practice patterns of gastroenterologists with comparison to the past two decades, J Clin Gastroenterol, 29, 339, 10.1097/00004836-199912000-00009

Christensen, 1990, Heraclides or the physician, Gastroenterol Int, 3, 45

Dalton, 2004, Perceptions of physicians and patients with organic and functional gastroenterological diagnoses, J Clin Gastroenterol Hepatol, 2, 121, 10.1016/S1542-3565(03)00319-7

Heitkemper, 2002, Women with irritable bowel syndrome, Gastroenterol Nurs, 25, 192, 10.1097/00001610-200209000-00004

Drossman, 2003, The “organification” of functional GI disorders, Gastroenterology, 124, 6, 10.1053/gast.2003.50024

Longstreth, 2005, Severe irritable bowel and functional abdominal pain syndromes, Clin Gastroenterol Hepatol, 3, 397, 10.1016/S1542-3565(05)00084-4

Engel, 1977, The need for a new medical model, Science, 196, 129, 10.1126/science.847460

Drossman, 1998, Presidential address, Psychosom Med, 60, 258, 10.1097/00006842-199805000-00007

Engel, 1980, The clinical application of the biopsychosocial model, Am J Psychiatry, 137, 535, 10.1176/ajp.137.5.535

Jones, 2006, Brain-gut connections in functional GI disorders, Neurogastroent Motil, 18, 91, 10.1111/j.1365-2982.2005.00730.x

Gwee, 1999, The role of psychological and biological factors in postinfective gut dysfunction, Gut, 44, 400, 10.1136/gut.44.3.400

Dunlop, 2003, Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfections IBS, Gastroenterology, 125, 1651, 10.1053/j.gastro.2003.09.028

Drossman, 1996, Health status by gastrointestinal diagnosis and abuse history, Gastroenterology, 110, 999, 10.1053/gast.1996.v110.pm8613034

Drossman, 2000, Effects of coping on health outcome among female patients with gastrointestinal disorders, Psychosom Med, 62, 309, 10.1097/00006842-200005000-00004

Drossman, 2000, What determines severity among patients with painful functional bowel disorders?, Am J Gastroenterol, 95, 974, 10.1111/j.1572-0241.2000.01936.x

Levy, 2004, Increased somatic complaints and health-care utilization in children, Am J Gastroenterol, 99, 2442, 10.1111/j.1572-0241.2004.40478.x

Kleinman, 1978, Culture, illness and care. Clinical lessons from anthropologic and cross-cultural research, Ann Intern Med, 88, 251, 10.7326/0003-4819-88-2-251

Stewart, 2000, The impact of patient-centered care on outcomes, J Fam Pract, 49, 796

Keefer, 2005, Towards a better understanding of anxiety in irritable bowel syndrome, J Cognitive Psychother, 19, 163, 10.1891/jcop.19.2.163.66794

Azpiroz, 2002, Anorectal functional testing, Am J Gastroenterol, 97, 232

Parkman, 2004, American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis, Gastroenterology, 127, 1592, 10.1053/j.gastro.2004.09.055

Pandolfino, 2004, AGA technical review on the clinical use of esophageal manometry, Gastroenterology, 128, 209, 10.1053/j.gastro.2004.11.008

Whitehead, 1994, Standardization of procedures for testing smooth muscle tone and sensory thresholds in the gastrointestinal tract, Dig Dis Sci, 42, 223, 10.1023/A:1018885028501

Drossman, 2005, Brain imaging and its implications for studying centrally targeted treatments in IBS, Gut, 54, 569, 10.1136/gut.2004.058446

Evans, 2004, Tegaserod for the treatment of irritable bowel syndrome 1, Cochrane Database Syst Rev, CD003960

Lembo, 2003, Alosetron in irritable bowel syndrome, Drugs, 63, 1895, 10.2165/00003495-200363180-00002

Galligan, 2005, Basic and clinical pharmacology of new motility promoting agents 1, Neurogastroenterol Motil, 17, 643, 10.1111/j.1365-2982.2005.00675.x

Sagami, 2004, Effect of a corticotrophin-releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome, Gut, 53, 958, 10.1136/gut.2003.018911

Drossman, 2003, Cognitive-behavioral therapy vs. education and desipramine vs. placebo for moderate to severe functional bowel disorders, Gastroenterology, 125, 19, 10.1016/S0016-5085(03)00669-3

Creed, 2003, The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome, Gastroenterology, 124, 303, 10.1053/gast.2003.50055

Chadwick, 2002, Activation of the mucosal immune system in irritable bowel syndrome, Gastroenterology, 122, 1778, 10.1053/gast.2002.33579

Gonsalkorale, 2003, Interleukin 10 genotypes in irritable bowel syndrome, Gut, 52, 91, 10.1136/gut.52.1.91

Yeo, 2004, Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women, Gut, 53, 1452, 10.1136/gut.2003.035451

Camilleri, 2002, Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome, Gastroenterology, 123, 425, 10.1053/gast.2002.34780

Holtmann, 2004, G-protein beta3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia, Gastroenterology, 126, 971, 10.1053/j.gastro.2004.01.006

Kim, 2004, Association of distinct alpha(2) adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders, Gut, 53, 829, 10.1136/gut.2003.030882

Caspi, 2003, Influence of life stress on depression, Science, 301, 386, 10.1126/science.1083968

Locke, 2000, Familial association in adults with functional gastrointestinal disorders, Mayo Clin Proc, 75, 907, 10.4065/75.9.907

Levy, 2001, Irritable bowel syndrome in twins, Gastroenterology, 121, 799, 10.1053/gast.2001.27995

Levy, 2000, Intergenerational transmission of gastrointestinal illness behavior, Am J Gastroenterol, 95, 451, 10.1111/j.1572-0241.2000.01766.x

Levy, 2001, Costs of care for irritable bowel syndrome patients in a health maintenance organization, Am J Gastoenterol, 96, 3122, 10.1111/j.1572-0241.2001.05258.x

Quigley, 2001, AGA technical review on nausea and vomiting, Gastroenterol, 120, 263, 10.1053/gast.2001.20516

Locke, 2000, AGA technical review on constipation, Gastroenterology, 119, 1766, 10.1053/gast.2000.20392

Drossman, 2002, AGA technical review on irritable bowel syndrome, Gastroenterology, 123, 2108, 10.1053/gast.2002.37095

Delgado-Aros, 2005, Visceral hypersensitivity 2, J Clin Gastroenterol, 39, S194, 10.1097/01.mcg.0000156114.22598.1b

Mayer, 1994, Basic and clinical aspects of visceral hyperalgesia, Gastroenterology, 107, 271, 10.1016/0016-5085(94)90086-8

Munakata, 1997, Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome, Gastroenterology, 112, 55, 10.1016/S0016-5085(97)70219-1

Barbara, 2004, Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome, Gastroenterology, 126, 693, 10.1053/j.gastro.2003.11.055

Gershon, 2005, Nerves, reflexes, and the enteric nervous system, J Clin Gastroenterol, 39, S184, 10.1097/01.mcg.0000156403.37240.30

Dunlop, 2005, Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome, Clin Gastroenterol Hepatol, 3, 349, 10.1016/S1542-3565(04)00726-8

Spiller, 2003, Post infectious irritable bowel syndrome, Gastroenterology, 124, 1662, 10.1016/S0016-5085(03)00324-X

Dunlop, 2003, Relative importance of enterochromaffin cell hyperplasia, anxiety and depression in post-infectious IBS, Gastroenterology, 125, 1651, 10.1053/j.gastro.2003.09.028

Stam, 2002, Long-lasting changes in central nervous system responsivity to colonic distention after stress in rats, Gastroenterology, 123, 1216, 10.1053/gast.2002.36029

Mayer, 2000, The neurobiology of stress and gastrointestinal disease, Gut, 47, 861, 10.1136/gut.47.6.861

Collins, 1992, Is the irritable gut an inflamed gut?, Scand J Gastroenterol, 27, 102, 10.3109/00365529209095988

McKendrick, 1994, Irritable bowel syndrome— post-salmonella infection, J Infection, 29, 1, 10.1016/S0163-4453(94)94871-2

Gwee, 1999, The role of psychological and biological factors in post-infective gut dysfunction, Gut, 44, 400, 10.1136/gut.44.3.400

Mearin, 2005, Dyspepsia after a Salmonella gastroenteritis outbreak, Gastroenterology, 129, 98, 10.1053/j.gastro.2005.04.012

Gwee, 2003, Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome, Gut, 52, 523, 10.1136/gut.52.4.523

Pimentel, 2000, Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome, Am J Gastroenterol, 95, 3503, 10.1111/j.1572-0241.2000.03368.x

O’Mahony, 2005, Lactobacillus and bifidobacterium in irritable bowel syndrome, Gastroenterol, 128, 541, 10.1053/j.gastro.2004.11.050

Svensson, 1987, Peripheral, autonomic regulation of locus coeruleus noradrenergic neurons in brain, Psychopharmacology, 92, 1, 10.1007/BF00215471

Valori, 1986, Effects of different types of stress and or “prokinetic” drugs on the control of the fasting motor complex in humans, Gastroenterology, 90, 1890, 10.1016/0016-5085(86)90258-1

Murray, 2004, Effect of acute physical and psychological stress on gut autonomic innervation in irritable bowel syndrome, Gastroenterology, 127, 1695, 10.1053/j.gastro.2004.08.057

Fukudo, 1998, Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome, Gut, 42, 845, 10.1136/gut.42.6.845

Tache, 2004, Corticotropin releasing factor receptor antagonists, Gut, 53, 919, 10.1136/gut.2003.036400

Tache, 2002, Role of corticotropin releasing factor subtype 1 in stress-related functional colonic alterations, Eur J Surg, 168, 16

Drossman, 1999, Mind over matter in the postinfective irritable bowel, Gut, 44, 306, 10.1136/gut.44.3.306

Dinan, 2006, Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome, Gastroenterology, 130, 304, 10.1053/j.gastro.2005.11.033

Hobson, 2004, Brain imaging and functional gastrointestinal disorders, Gut, 53, 1198, 10.1136/gut.2003.035642

Hobson, 2005, Real-time imaging of human cortical activity evoked by painful esophageal stimulation, Gastroenterology, 128, 610, 10.1053/j.gastro.2004.12.033

Yaguez, 2005, Brain response to visceral aversive conditioning, Gastroenterology, 128, 1819, 10.1053/j.gastro.2005.02.068

Kern, 2002, Cerebral cortical registration of subliminal visceral stimulation, Gastroenterology, 122, 290, 10.1053/gast.2002.30989

Mertz, 2000, Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention, Gastroenterolgy, 118, 842, 10.1016/S0016-5085(00)70170-3

Naliboff, 2001, Cerebral activation in irritable bowel syndrome patients and control subjects during rectosigmoid stimulation, Psychosom Med, 63, 365, 10.1097/00006842-200105000-00006

Drossman, 2003, Alterations of brain activity associated with resolution of emotional distress and pain in a case of severe IBS, Gastroenterology, 124, 754, 10.1053/gast.2003.50103

Chang, 2003, Brain responses to visceral and somatic stimuli in patients with irritable bowel syndrome with and without fibromyalgia, Am J Gastroenterol, 98, 1354, 10.1111/j.1572-0241.2003.07478.x

Hobday, 2001, A study of the cortical processing of ano-rectal sensation using functional MRI, Brain, 124, 361, 10.1093/brain/124.2.361

Verne, 2001, Central representation of cutaneous and visceral pain in irritable bowel syndrome, Gastroenterology, 120, A713, 10.1016/S0016-5085(08)83551-2

Morgan, 2001, Anxiety is associated with increased anterior cingulate but not thalamic activation during rectal pain in IBS and controls, Gastroenterology, 120, 3850

Ringel, 2003, Association of anterior cingulate cortex (ACC) activation with psychosocial distress and pain reports, Gastroenterology, 124, A–97, 10.1016/S0016-5085(03)80477-8

Ringel, 2003, Regional brain activation in response to rectal distention in patients with irritable bowel syndrome and the effect of a history of abuse, Dig Dis Sci, 48, 1774, 10.1023/A:1025455330704

Ringel, 2003, IBS diagnosis and a history of abuse have synergistic effect on the perigenual cingulate activation in response to rectal distention, Gastroenterology, 124, A–531, 10.1016/S0016-5085(03)82688-4

Lackner, 2005, Cognitive therapy for irritable bowel syndrome is associated with reduced limbic activity, GI symptoms, and anxiety, Behav Res Ther, 43, 943, 10.1016/j.brat.2004.06.018

Morgan, 2005, Amitriptyline reduces rectal pain-related activation of the anterior cingulate cortex in patients with irritable bowel syndrome, Gut, 54, 601, 10.1136/gut.2004.047423

Drossman, 1995, Diagnosing and treating patients with refractory functional gastrointestinal disorders, Ann Intern Med, 123, 688, 10.7326/0003-4819-123-9-199511010-00008

Drossman, 2003, Psychosocial factors in the care of patients with GI disorders, 636

Chang, 2002, Optimizing patient care, Clin Perspect Gastroenterol, 5, 336

Drossman, 1999, The physician-patient relationship, 133

Lipkin, 1995

Roter, 1998, Effectiveness of interventions to improve patient compliance, Med Care, 36, 1138, 10.1097/00005650-199808000-00004

Ilnyckyj, 2003, Therapeutic value of a gastroenterology consultation in irritable bowel syndrome, Aliment Pharmacol Ther, 17, 871, 10.1046/j.1365-2036.2003.01523.x

Drossman, 1992, The irritable bowel syndrome, Ann Intern Med, 116, 1009, 10.7326/0003-4819-116-12-1009

Torsoli, 1991, The WTR’s, the Delphic Oracle and the Roman Conclaves, Gastroenterol Int, 4, 44

Milholland, 1973, Medical assessment by a delphi group opinion technique, N Engl J Med, 298, 1272, 10.1056/NEJM197306142882405

Drossman, 1998, Do the Rome criteria stand up, 11

Whitehead, 1996, Functional bowel disorders, 65

Whitehead, 2003, Factor analysis of bowel symptoms in U.S. and Italian populations, Dig Liver Dis, 35, 774, 10.1016/S1590-8658(03)00456-0

Camilleri, 2005, Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States, Clin Gastroenterol Hepatol, 3, 543, 10.1016/S1542-3565(05)00153-9

Saito, 2002, The epidemiology of irritable bowel syndrome in North America, Am J Gastroenterol, 97, 1910

Wigington, 2005, Epidemiology of irritable bowel syndrome among African Americans as compared with whites, Dig Dis, 3, 647

Gwee, 2005, Irritable bowel syndrome in developing countries—a disorder of civilization or colonization?, 2. Neurogastroenterol Motil, 17, 317, 10.1111/j.1365-2982.2005.00627.x

Whitehead, 1990, Existence of irritable bowel syndrome supported by factor analysis of symptoms in two community samples, Gastroenterology, 98, 336, 10.1016/0016-5085(90)90822-I

Manning, 1978, Towards positive diagnosis of the irritable bowel, Br Med J, 2, 653, 10.1136/bmj.2.6138.653

Thompson, 2002, Functional gastrointestinal disorders in Canada, Dig Dis Sci, 47, 225, 10.1023/A:1013208713670

1994

Lembo, 1999, Symptoms and visceral perception in patients with pain-predominant irritable bowel syndrome, Am J Gastroenterol, 94, 1320, 10.1111/j.1572-0241.1999.01009.x

Bayless, 1990, Inflammatory bowel disease and irritable bowel syndrome, Med Clin N Am, 49, 21, 10.1016/S0025-7125(16)30583-1

Isgar, 1983, Symptoms of irritable bowel syndrome in ulcerative colitis in remission, Gut, 24, 190, 10.1136/gut.24.3.190

Quigley, 2005, Irritable bowel syndrome and inflammatory bowel disease, Chinese J Dig Dis, 6, 122, 10.1111/j.1443-9573.2005.00202.x